Ligand validation:4RVN

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 4RVN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RVN_AMP_D_502	84%	65%	0.094	0.957	0.57	0.76	-	1	2	0	100%	1
4RVN_AMP_C_502	84%	65%	0.109	0.971	0.57	0.76	-	1	3	0	100%	1
4RVN_AMP_B_502	82%	62%	0.103	0.958	0.6	0.81	-	2	2	0	100%	1
4R1L_AMP_A_503	80%	60%	0.134	0.983	0.69	0.82	-	1	0	0	100%	0.5
4R1M_AMP_B_502	70%	60%	0.146	0.964	0.64	0.86	-	2	0	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3CLT_AMP_C_1262	100%	42%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
3CLR_AMP_C_1262	100%	42%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1
5NRH_AMP_B_700	99%	36%	0.051	0.989	1.23	1.39	3	2	0	0	100%	1
4M0K_AMP_D_300	99%	41%	0.047	0.983	0.89	1.43	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.